| Literature DB >> 31974669 |
Suzan Dijkink1, Karien Meier2, Pieta Krijnen2, D Dante Yeh3, George C Velmahos4, Inger B Schipper2.
Abstract
PURPOSE: In hospitalized patients, malnutrition is associated with adverse outcomes. However, the consequences of malnutrition in trauma patients are still poorly understood. This study aims to review the current knowledge about the pathophysiology, prevalence, and effects of malnutrition in severely injured patients.Entities:
Keywords: Adverse outcomes; Malnutrition; Nutrition; Polytrauma; Severe injuries; Trauma
Mesh:
Year: 2020 PMID: 31974669 PMCID: PMC7593306 DOI: 10.1007/s00068-020-01304-5
Source DB: PubMed Journal: Eur J Trauma Emerg Surg ISSN: 1863-9933 Impact factor: 3.693
Fig. 1Studies resulting from literature search with reasons for in-/exclusion
Included cohort studies about prevalence of malnutrition and its effects on outcomes in trauma patients in this review (n = 10)
| References | Year | Country | Design | Male (%) | Age in years | Nutritional assessment tool | Prevalence MN on admission (unless indicated otherwise) (%) | ARM (%) | Mortality | Length of stay in days | Complications | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wilson et al. [ | 2019 | United States | Prospective cohort study | 377 | 50.9 | 73.70m ± SD 12.73 | Visceral proteins | Hypoalbuminaemia: 17.5 Low TLC: 62.3 | – | Hypoalbuminaemia: OR2.22 95% CI 1.26–3.92 TLC: n/a | Hypoalbuminaemia: TLC:n/a | ≥ 1 adverse event associated with MN, |
| Wilson et al. [ | 2019 | United States | Retrospective cohort study | 5673 | 43.8 | 46.69m ± SD 13.62 | Visceral proteins | Hypoalbuminaemia: 29.6 | WN: 0.4%, MN: 3.2%, RR 4.86, 95% CI 2.66–8.87 | WN: 3.57 (± SD 5.0) MN: 7.5 (± SD 10.45) | ≥ 1 adverse event RR 1.46 95% CI 1.30–1.64; Sepsis RR 1.99 95% CI 1.03–3.86; Unplanned intubation RR 2.95 95% CI 1.49–5.84; Reoperation RR 1.52 95% CI 1.11–2.07; Readmission RR 2.0 95% CI 1.55–2.57 | |
| Wintermeyer et al. [ | 2019 | Germany | Prospective cohort study | 1642 | – | 57.8m ± SD 16.6 | NRS | – | Overall: 18.3 Geriatric trauma: 35.6 | – | – | ≥ 1 adverse event associated with ARM, |
| Ihle et al. [ | 2017 | Germany | Prospective cohort study | 521 | 56.2 | 53.9m ± SD 18.1 | NRS | – | 19.2 | – | NRS ≥ 3 (ARM): 16 ± SD 12 NRS < 3 (WN): 11 ± SD 10 | ≥ 1 adverse event associated with ARM, |
| Müller et al. [ | 2017 | Switzerland | Non-comparative prospective cohort study | 169 | 42.6 | 79.7m ± SD 6.5 | MNA | 7.1 | 49.1 | – | – | – |
| Goisser et al. [ | 2015 | Germany | Non-comparative retrospective cohort study | 97 | 20.6 | 84.0m ± SD 5.0 | MNA (long form) | 17.0 | 38.0 | WN:13%, ARM: 21%, MN: 0%, | WN:11med IQR 10–16, ARM:12med IQR 9–17, MN:10med IQR 7–15, | WN: 86%, ARM: 97%, MN: 100%, |
| Chakravarty et al. [ | 2013 | India | Non-comparative prospective cohort study | 61 | 78.7 | – | SGA | 15.0 | – | – | – | – |
| Banks et al. [ | 2010 | Ireland | Non-comparative prospective cohort study | 30 | 37.0 | 78.5med IQR 68–85 | MNA | – | 60.0 | – | – | – |
| Dhandapani et al. [ | 2007 | India | Non-comparative prospective cohort study | 61 | 92.0 | 35.4m ± SD not reported | Anthropometric measurements | Clinical features of pedal edema, cheilosis, skeletal prominence, xerosis, gum bleed: Week 1: 45.0 Week 3: 76.0 | – | – | – | |
| Goiburu et al. [ | 2006 | Paraguay | Non-comparative prospective cohort study | 161 | 94.0 | 27.0med IQR 14–92 | SGA | 40.0 | – | RR 4; 95% CI 1–15 | > 14 days RR 2.3; 95% CI 1.2–4.7 | RR 2.9; 95% CI 1.4–5.8 |
| Compan et al. [ | 1999 | France | Non-comparative prospective cohort study | 299 | 33.0 | 82.9m ± SD 7.0 | MNA | 24.7 | – | – | Longer stay associated with MN, p not reported | Death during hospitalization associated with MN, |
| McClave et al. [ | 1992 | United States | Non-comparative prospective cohort study | – | – | – | Visceral proteins Anthropometric measurements | Low visceral proteins (albumin, transferrin, TLC): 17.6%, Underweight: 20.6%, Mix: 15.6% | OR 4.04; | OR 1.29; | Sepsis: OR 2.64; | |
| Kaufman et al. [ | 1987 | United States | Non-comparative prospective cohort study | 76 | – | – | Visceral proteins Anthropometric measurements | Albumin, transferrin, TLC, and others: not defined | - | – | – | – |
MN Malnourished, ARM At risk for malnutrition, WN Well−nourished, NRS Nutritional Risk Screening, MNA Mini Nutritional Assessment, SGA Subjective Global Assessment scale, TLC Total lymphocyte count, SD Standard deviation, IQR Interquartile range, RR relative risk, C: confidence interval, OR adjusted odds ratio
*n refers to the number of trauma patients in the study
m mean
med median
Risk of Bias in the included cohort studies according to Methodological Index for Non-Randomized Studies (MINORS) criteria [16]
| Wilson et al. [ | Wilson et al. [ | Wintermeyer et al. [ | Ihle et al. [ | Müller et al. [ | Goisser et al. [ | Chakravarty et al. [ | Banks et al. [ | Dhandapani et al. [ | Goiburu et al. [ | Compan et al. [ | McClave et al. [ | Kaufman et al. [ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Clearly stated aim | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| 2. Inclusion of consecutive patients | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 0 |
| 3. Prospective collection of data | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 0 |
| 4. Endpoints appropriate to aim of study | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 2 |
| 5. Unbiased assessment of study endpoints | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 2 | 2 | 0 | 1 | 0 | 0 |
| 6. Follow-up period appropriate to aim of study | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 7. < 5% lost to follow-up | 2 | 1 | 2 | 2 | 0 | 2 | 2 | 1 | 1 | 1 | 0 | 2 | 1 |
| 8. Prospective calculation of study size | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 |
| Total | 14 | 13 | 14 | 12 | 14 | 14 | 12 | 14 | 14 | 12 | 12 | 7 | 7 |
Criteria were scored 2 (reported and adequate), 1 (reported but inadequate) or 0 (not reported), with a maximum total score of 16
Fig. 2Model of effects of the hypermetabolic state and malnutrition in severely injured patients